Chengke Luo
No.87, Xiangya Road
Changsha, 410008, China
Changsha, 410008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Bibliometric analysis of programmed cell death and immunotherapy research in glioma.
Journal: Discover oncology
Published: April 06, 2026
Risk factors for olfactory dysfunction after transsphenoidal pituitary adenoma resection: A systematic review and meta-analysis.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: March 13, 2026
circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 02, 2023
Correction: Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma.
Journal: Cell death & disease
Published: September 19, 2022
Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma.
Journal: Cell death & disease
Published: May 27, 2022
A Nanoparticle-Conjugated Anti-TBK1 siRNA Induces Autophagy-Related Apoptosis and Enhances cGAS-STING Pathway in GBM Cells.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 07, 2021
Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
Journal: Frontiers in immunology
Published: June 26, 2021
A Novel Mice Model for Studying the Efficacy and IRAEs of Anti-CTLA4 Targeted Immunotherapy.
Journal: Frontiers in oncology
Published: April 08, 2021
Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas.
Journal: Frontiers in cell and developmental biology
Published: August 12, 2020
Immune-related genes with APA in microenvironment indicate risk stratification and clinical prognosis in grade II/III gliomas.
Journal: Molecular therapy. Nucleic acids
Published: August 06, 2020
A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high-grade glioma.
Journal: Clinical and translational medicine
Published: July 20, 2020
Last Updated: 09/26/2026